Medical Affairs Resources, Structures, & Trends Report Summary

•Download as PPT, PDF•

2 likes•873 views

Best Practices, LLC

Research Objective Key Topic Areas Study Objective Objective: This survey was developed to identify benchmarks for resources, structures and activities of Medical Affairs organizations within leading pharmaceutical, medical device and biotech companies. Metrics and insights developed from survey data may be used to evaluate and improve Medical Affairs organizations throughout the industry. ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Definitions Used in This Report The following definitions are used in this study. ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Selected Key Findings The following key findings and insights are among those that emerged from the field surveys and executive interviews. ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Research Participants ,[object Object],Participants in Survey Participating Companies: Amgen, ApoPharma, Astellas, AstraZeneca, Auxilium, Bayer Healthcare, Bayer Schering Pharma, Becton Dickinson, Bristol-Myers Squibb, Cubist, Esteve, Genentech, Johnson & Johnson, Myriad, Novartis, Novo Nordisk, OctoPlus, Pfizer, ProCaps, Savient, Schering-Plough, SK&F, Solvay, Vertex, Werrick Pharmaceuticals. Werrick Pharmaceuticals

Medical Affairs Departments Have High-Level Leadership ,[object Object],Q. What is the job level of the person who currently heads Medical Affairs? n=26 * Other= Head of Medical Affairs; Manager of Medical Affairs Chief Medical Officer Senior/Executive VP Vice President Senior/Executive Director, 19% Director, 19% * Other, 8% 23% 4% 27% Job Level of Medical Affairs Head

Half the Medical Affairs Organizations Have Global Span ,[object Object],Q. What is the geographic span of responsibility of Medical Affairs at your company? n=26 * Other =Global (excluding US), North America, Hybrid, No reporting line between Global Medical Affairs & Regional/local Medical Affairs; Country Only (4 responses) * Geographic Span of Medical Affairs Head % Responses

[object Object],Q. Please describe the key reasons for an decreases in spending or headcount that you indicated occurred in the past year or that you anticipate next year. ,[object Object],[object Object],“ The company has initiatives to do more with less.” “ Laboratory operations functions are being moved out of Medical Affairs next year.” “ Products are going off patent.” “ Economy.” “ Acquisition of another company.” Representative Quotes: Few Companies Decreasing Medical Affairs Resources Cite Varied Reasons $ Medical Affairs Medical Affairs $

About Best Practices, LLC Best Practices, LLC is a research and consulting firm that conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC 6350 Quadrangle Drive, Suite 200, Chapel Hill, NC 27517 919-403-0251 [email_address] www3.best-in-class.com

The Medical Affairs function plays an important role in health outcomes (HO) information exchange between bio-pharmaceutical organizations and key external stakeholders. Development of robust health outcomes capabilities within Medical Affairs function requires an increase in the function’s involvement with health outcomes groups, development of field-based health outcomes capabilities, customization of health outcomes data as per stakeholders’ needs, and building real world data capabilities to generate and utilize health outcomes information. This benchmarking research from Best Practices, LLC is designed to assist companies focused on oncology therapies find better ways to develop effective health outcomes groups. It provides current data and best practices from Medical Affairs leaders with an oncology focus at leading bio-pharmaceutical companies. Download Full Report: http://bit.ly/2e3sl9Q

Benchmarking the Pharma Industry’s Medical Affairs Functions

Industry Standard Research

Medical Affairs, as a function, sits at a crossroads in the pharmaceutical industry. The department is expected to act as a bridge between the commercial and scientific arms of an organization. Medical Affairs is further tasked with being the conduit of information between the company and external stakeholders, bringing efficacy and safety data to the medical community as well as gathering insights from the medical community to share internally. All responsibilities must be undertaken while keeping in mind strict regulatory controls and ensuring that medical data are interpreted appropriately. ISR has designed this report to be used as a benchmarking tool for companies to compare their Medical Affairs functions to those of Top 50 pharmaceutical organizations. See more: http://bit.ly/medaffairs

Medical & Scientific Affairs (M & SA)

Dr Karthik Anantharaman

Medical Affairs Leadership Summit, Key APAC Insights - August 2016Lynn Okamoto

Benchmarking Advisory Board Management At Large Pharmaceutical And Medical De...

Best Practices

Pharmaceutical advisory boards provide strategic inputs and guidance to organizations on various business aspects. However, successful advisory board management requires optimum investment in resources and operations. To maximize the return on investment it is important for pharmaceutical and medical device professionals to ensure that the quality of meetings and dialogue with advisory boards is excellent. This research from Best Practices, LLC is designed for pharmaceutical and biotech executives seeking ways to best utilize the knowledge of advisory boards. Research findings provide benchmarks on the appropriate structure for various types of advisory boards, selection of advisory board participants, advisory board operational and resource benchmarks.

Medical affairs department for small organization

Dr. Zubair Ali

Strategic Medical Affairs in pharma and medical devices

Anjan Banerjee

Medical Affairs Consortium

Best Practices

This presentation gives an insight into the membership benefits of Best Practices, LLC’s Medical Affairs Consortium. It also highlights some of the key benchmarks and best practices that emerged from Medical Affairs Consortium. The Medical Affairs Consortium at Best Practices, LLC provides a dedicated platform to Medical Affairs Leaders to discuss top challenges, develop action oriented solutions, share best practices & lessons learned and explore current and future trends with regards to the Medical Affairs function and its interactions with other critical functions. Topics for the Medical Affairs Consortium are usually determined by member requests. The Medical Affairs Consortium addresses three key areas: • Building Strong Medical Affairs Capabilities • Medical Affairs Launch Support Excellence • Medical Affairs’ Critical Role in Health Economics & Outcomes Research

From Social Media through to Artificial intelligence...and more. In this presentation I covered the trends that we're currently seeing in Medical Affairs - those trends which are important now, those trends which will impact Medical Affairs in the future, and the skills required to be successful. To read the LinkedIn article here’s the link: https://www.linkedin.com/pulse/trends-medical-affairs-presented-appa-march-14-2018-glenn-carter/ For further discussion phone us on: Sydney (02) 8877 8777 Melbourne (03) 9938 7100 Or for additional insights go to one of our specialised websites: Healthcare Professionals Group (https://www.hpgconnect.com/) Health & Aged Care Professionals (https://www.hacpconnect.com/) Pharmaceutical & Medical Professionals (https://www.pmpconnect.com/) Rural & Remote Healthcare Professionals (https://www.rrhpconnect.com/)

Benchmarking Professional Medical Education Excellence Structures

Best Practices

Continuing Medical Education (CME) programs serve to maintain, develop or enhance the skills, knowledge and professional performance & relationships that a physician uses to provide services to patients, public and the profession. However, recent compliance and transparency rules have tempered the sponsorship of some medical education programs by bio-pharmaceutical companies as well as some third-party providers of such services. Critics such as Morris and Taitsman also prefer that the medical profession eliminate commercial support for CME. Best Practices, LLC conducted this study to inform those who lead medical education programs at large bio-pharmaceutical companies about the proper size, resourcing and structure for the medical education function. The study looks into emerging Medical Education trends at medical device and pharmaceutical organizations regarding funding and program types. Download Full Report: http://bit.ly/2bAUm6U

Development Msl

dlcram

Benchmarking Bio-Pharmaceutical Medical Education Programs: Structures, Resou...

Best Practices

Bio-pharmaceutical organizations have long relied on medical education programs to provide latest medical knowledge to physicians and other health care professionals. However, recent compliance rules and regulations have tempered the sponsorship of some medical education programs by bio-pharmaceutical companies, as well as some third-party providers of such services. Best Practices, LLC, undertook benchmarking research to probe emerging medical education trends at top bio-pharmaceutical companies. In particular, this research provides benchmarks on the proper size, structure, activities performed, staffing, and investment for the Medical Education function. Download Full Report: http://bit.ly/2cf5PYb

Emerging Medical Education Trends in the Medical Device Industry: Benchmarks ...

Best Practices

Medical education programs play an important role in informing health care professionals about the safe and effective use of medical devices. To probe emerging medical education trends in the device sector, Best Practices, LLC undertook benchmarking research. In particular, this study provides benchmarks on the proper size, structure, funding channels, staffing and investment for medical education groups. Download Full Report: http://bit.ly/2bY2NZ8

Professional Medical Education Excellence Pharma

Best Practices

Physician Strategies

jpzito

Medical Affairs Excellence Services Summary

Marty Daniel with ThunderActive

Highlights From 7th Medical Science Liaison/MSL Conference

ExL Pharma

Medical Affairsmbielick

Coaching Action Plan for MSL - Investigator Initiated TrialsMarieke Jonkman PharmD

Medical Science Liaison-Aligning The Activities And Goals Of Medical Science ...

Medical Science Liaison Society

Aligning the Activities and Goals of Field Based Teams for Strengthened Corporate Sustainability • Examining the disconnect between field based medical and corporate initiatives • Acquiring and synthesizing field insights to drive clinical and corporate decision-making • Demonstrating value of the expensive MSL and Advisor roles to the company The Medical Science Liaison role is growing and being utilized in a number of various ways by different companies. This presentation discussed how they are being utilized.

Medical Affairs Resources, Structures, and Trends Report Summary

Best Practices, LLC

Digitized healthFrank Wang

Edifecs CJR: don't fumble with your bundle ss

Edifecs Inc

Comprehensive Care for Joint Replacement (CJR) opens the door to opportunity for improved joint replacement patient care delivery. With full accountability for both cost and quality for the joint replacement episode, hospitals must share critical data in near real time to align and coordinate the full continuum of post-acute providers. The top complexities Jay Sultan addressed include: The top complexities Jay Sultan addressed include: Considerations for entering into contracts with your orthopedic surgeons and other collaborating episode providers Episode bundle administration and monitoring; gain sharing administration Real-time data acquisition from collaborating providers Analytics and reporting, focused care delivery management, and preparation for CMS audits Whatever burning issues and questions are on your mind

Preventive Health Services at the Workplace 6.2.08

Leonard Davis Institute of Health Economics

Highlights from ExL Pharma's 6th MSL Best PracticesExL Pharma

HIDA Thought Leaders Paper Rodney RottonRodney Cotton

BlockbusterJan Malek

Rodney POCRodney Cotton

Medical Affairs Resources, Structures, and Trends (UPDATE) - Report Summary

Best Practices

The Update to the wildly popular Medical Affairs Resources, Structures, and Trends research from 2009 is ready! Contains linear data and new segmentation for emerging markets. Charged with building and maintaining physician relationships, pharmaceutical Medical Affairs organizations typically oversee several important functions -- including publications, KOL programs, grants and medical education (CME) -- that have been impacted in recent years by a call for increased transparency. As such, forward-looking biopharmaceutical executives are beginning to evaluate Medical Affairs operations to ensure that the vital organization is appropriately structured and resourced to operate effectively in the current environment. This Best Practices, LLC study explores how U.S. and global biopharmaceutical companies are structuring and managing their Medical Affairs organizations today. The study also examines recent trends in budget and staffing resources, key challenges and top success factors for the function. The report is based on the insights of 68 Medical Affairs executives and managers at 50 leading global companies. The benchmark class in this study consists of a Mature Markets and Emerging Markets Segment. The Mature Market Segment includes 41 participants from pharma and 12 device respondents. The Emerging Markets Segment consists of 15 participants working in India, China, Brazil, and Turkey.

Medical Affairs Resources, Structures & Trends Report Summary

Best Practices

What's hot

Trends in Medical Affairs

Pharmaceutical & Medical Professionals

Benchmarking Professional Medical Education Excellence Structures

Best Practices

Development Msl

dlcram

Benchmarking Bio-Pharmaceutical Medical Education Programs: Structures, Resou...

Best Practices

Emerging Medical Education Trends in the Medical Device Industry: Benchmarks ...

Best Practices

Professional Medical Education Excellence Pharma

Best Practices

Physician Strategies

jpzito

Medical Affairs Excellence Services Summary

Marty Daniel with ThunderActive

Highlights From 7th Medical Science Liaison/MSL Conference

ExL Pharma

Medical Affairsmbielick

Coaching Action Plan for MSL - Investigator Initiated TrialsMarieke Jonkman PharmD

Medical Science Liaison-Aligning The Activities And Goals Of Medical Science ...

Medical Science Liaison Society

Medical Affairs Resources, Structures, and Trends Report Summary

Best Practices, LLC

Digitized healthFrank Wang

Edifecs CJR: don't fumble with your bundle ss

Edifecs Inc

Preventive Health Services at the Workplace 6.2.08

Leonard Davis Institute of Health Economics

Highlights from ExL Pharma's 6th MSL Best PracticesExL Pharma

HIDA Thought Leaders Paper Rodney RottonRodney Cotton

BlockbusterJan Malek

Rodney POCRodney Cotton

What's hot (20)

Trends in Medical Affairs

Benchmarking Professional Medical Education Excellence Structures

Development Msl

Benchmarking Bio-Pharmaceutical Medical Education Programs: Structures, Resou...

Emerging Medical Education Trends in the Medical Device Industry: Benchmarks ...

Professional Medical Education Excellence Pharma

Physician Strategies

Medical Affairs Excellence Services Summary

Highlights From 7th Medical Science Liaison/MSL Conference

Medical Affairs

Coaching Action Plan for MSL - Investigator Initiated Trials

Medical Science Liaison-Aligning The Activities And Goals Of Medical Science ...

Medical Affairs Resources, Structures, and Trends Report Summary

Digitized health

Edifecs CJR: don't fumble with your bundle ss

Preventive Health Services at the Workplace 6.2.08

Highlights from ExL Pharma's 6th MSL Best Practices

HIDA Thought Leaders Paper Rodney Rotton

Blockbuster

Rodney POC

Similar to Medical Affairs Resources, Structures, & Trends Report Summary

Medical Affairs Resources, Structures, and Trends (UPDATE) - Report Summary

Best Practices

Medical Affairs Resources, Structures & Trends Report Summary

Best Practices

A Day in the Life of a Medical DirectorPharmaceutical & Medical Professionals

Models & Trends in REMS Program Success

Best Practices

Given the stringent regulatory requirements in the health care industry, it is important for bio-pharmal companies to develop innovative Risk Evaluation and Mitigation Strategies (REMS) plans during the commercialization of certain products to ensure an acceptable risk-to-benefit ratio. This benchmark study published by Best Practices, LLC examines how companies develop and execute successful Risk Evaluation and Mitigation Strategies (REMS) plans for newly-approved drugs in the U.S. market. This study can help bio-pharma companies in creating successful REMS programs. Download Full Report: http://bit.ly/2aOt5Id

Best-in-Class Strategies to Develop Effective Medical Information Groups

Best Practices

Medical information groups within bio-pharmaceutical companies play a vital role in the management of publications and product inquiries during the commercialization of drugs. However, recent regulatory changes in the industry have made it imperative for the Medical Affairs function to align its medical information activities with compliance requirements. This Best Practices, LLC report establishes benchmarks on the critical requirements to create strong medical information groups. In particular, this report identifies best practices in internal collaboration, alignment of information activities with compliance requirements and the structure, leadership and resource levels required to develop best-in-class medical information groups. Download Full Report: http://bit.ly/2ewac07

Pfizer Inccmcmarist8

EIU Value ChallengeAnita Burrell

Strategies to Increase Medical Affairs' Role in Health Outcomes Data Generati...

Best Practices

With the shift toward evidence-based medicine and value-based pricing, many bio-pharmaceutical companies are transitioning their Health Economics and Outcomes Research (HEOR) function away from the Commercial organization to Medical Affairs. This has some major implications towards the interactions with key stakeholders, the way interactions are documented and the skill sets & activities that may be required. Development of strong health outcomes capabilities within Medical Affairs organizations requires an increase in that function’s involvement with health outcomes groups, development of field-based health outcomes capabilities, customization of health outcomes data by stakeholders and building real world data capabilities to generate and utilize health outcomes information. Best Practices, LLC undertook this study to identify strategies to increase MA’s role in Health Outcomes data generation and utilization. Specifically, the study highlights the role of Medical Affairs function in HO activities, industry drivers and resource levels for HO groups, challenges of MA’s involvement in HO activities and strategies for effective HO data communication and utilization. Download Full Report: http://bit.ly/2dGFAbz

2nd Annual Medical Affairs Leaders Forum Asia- August 5th - 6th, 2014

Medical Science Liaison Society

PREPARATIONConsider the hospital-acquired conditions that ar.docx

keilenettie

PREPARATION Consider the hospital-acquired conditions that are not reimbursed for under Medicare/Medicaid. Among these conditions are specific safety issues such as infections, falls, medication errors, and other safety concerns that could have been prevented or alleviated with the use of evidence-based guidelines. Hospital Safety Score, an independent nonprofit organization, uses national performance measures to determine the safety score for hospitals in the United States. The Hospital Safety Score Web site and other online resources provide hospital safety scores to the public. Read the scenario below: Scenario As the manager of a unit, you have been advised by the patient safety office of an alarming increase in the hospital safety score for your unit. This is a very serious public relations matter because patient safety data is public information. It is also a financial crisis because the organization stands to lose a significant amount of reimbursement money from Medicare and Medicaid unless the source of the problem can be identified and corrected. You are required to submit a safety score improvement plan to the organization's leadership and the patient safety office. Select a specific patient safety goal that has been identified by an organization, or one that is widely regarded in the nursing profession as relevant to quality patient care delivery, such as patient falls, infection rates, catheter-induced urinary infections, IV infections, et cetera. DELIVERABLE: SAFETY SCORE IMPROVEMENT PLAN Develop a 3–5 page safety score improvement plan. Identify the health care setting and nursing unit of your choice in the title of the mitigation plan. For example, "Safety Score Improvement Plan for XYZ Rehabilitation Center." You may choose to use information on a patient safety issue for the organization in which you currently work, or search for information from a setting you are familiar with, perhaps from your clinical work. Demonstrate systems theory and systems thinking as you develop your recommendations. Organize your report with these headings: Study of Factors Identify a patient safety issue. Describe the influence of nursing leadership in driving the needed changes. Apply systems thinking to explain how current policies and procedures may affect a safety issue. Recommendations Recommend an evidence-based strategy to improve the safety issue. Explain a strategy to collect information about the safety concern. How would you determine the sources of the problem? Explain a plan to implement a recommendation and monitor outcomes. What quality indicators will you use? How will you monitor outcomes? Will policies or procedures need to be changed? Will nursing staff need training? What tools will you need to do this? Additional Requirements Written communication: Written communication should be free of errors that detract from the overall message. APA formatting: Resources and in-te ...

Medical Science Liaison Webinarv 2009

Cameron Tew

Roles, Resources, and Managemet of Medical Science LiaisonsBest Practices, LLC

Strategic Audit MillerJanice Miller

Corporate Affairs ExcellenceBest Practices, LLC

C H A P T E R 5S T R A T E G I C P L A N N I N G A N D

TawnaDelatorrejs

C H A P T E R 5 S T R A T E G I C P L A N N I N G A N D S W O T A N A L Y S I S I s k a t e w h e r e t h e p u c k i s g o i n g t o b e , n o t w h e r e i t h a s b e e n . — W a y n e G r e t z k y K e y T e r m s a n d C o n C e p T s ➤➤ Force➤field➤analysis ➤➤ Opportunities ➤➤ Strengths ➤➤ SWOT➤analysis ➤➤ Threats ➤➤ Weaknesses 9 1 Excerpted from Essentials of Strategic Planning in Healthcare by Jeffrey P. Harrison (Health Administration Press, 2010). 9 2 E s s e n t i a l s o f S t r a t e g i c P l a n n i n g i n H e a l t h c a r e In T r o d u C T I o n Healthcare organizations must continually make adjustments to maintain optimal function (Christiansen 2002). A number of different techniques can be used to determine where adjustments need to be made. One essential technique involves a discussion of an organization’s strengths, weaknesses, opportunities, and threats, commonly called SWOT analysis. SWOT analysis has been used extensively in other industries but has not been widely used in healthcare (Kahveci and Meads 2008). SWOT analysis is a precursor to strategic planning and is performed by a panel of experts who can assess the organization from a critical perspective (Gibis et al. 2001). This panel could comprise senior leaders, board members, employees, medical staff, patients, community leaders, and technical experts. Panel members base their assessments on utilization rates, outcome measures, patient satisfaction statistics, organizational performance measures, and financial status. While based on data and facts, the conclusions drawn from SWOT analysis are an expert opinion of the panel. de f I n I T I o n SWOT analysis is an examination of an organization’s internal strengths and weaknesses, its opportunities for growth and improvement, and the threats the external environment presents to its survival. Originally designed for use in other industries, it is gaining increased use in healthcare. sT e p s I n sWoT an a l y s I s The primary aim of strategic planning is to bring an organization into balance with the external environment and to maintain that balance over time (Sackett, Jones, and Erdley 2005). Organizations accomplish this balance by evaluating new programs and services with the intent of maximizing organizational performance. SWOT analysis is a prelimi- nary decision-making tool that sets the stage for this work. Step 1 of SWOT analysis involves the collection and evaluation of key data. De- pending on the organization, these data might include population demographics, community health status, sources of healthcare funding, and/or the current status of medical technology. Once the data have been collected and analyzed, the organization’s capabilities in these areas are assessed. In Step 2 of SWOT analysis, data on the organization are collected and sorted into four categories: strengths, weaknesses, opportunities, and threats. Stre ...

Dashboard Benchmark Evaluation Diabetes Essay.docx

studywriters

Catasys, Inc. Executive Informational Overview Introduction

Crystal Research Associates

The Business Case for QualityDecision making in todays health car.docx

anhcrowley

The Business Case for Quality Decision making in today's health care organizations requires a continuous balancing act, often involving tradeoffs to meet various clinical and business needs. For decisions related to quality, it is especially important to be able to provide a sound rationale for the choices that are made. To prepare for this Discussion: Bring to mind a specific quality or safety challenge that might be encountered in a health care organization (choose a type of organization that is of particular interest to you). Review the information presented in the Learning Resources, including the "Making the Business Case for Quality Management" section on pages 128–141 in Medical Quality Management. Must use this artcile. I will post below. Article: Leatherman, S., Berwick, D., Iles, D., Lewin, L. S., et al. (2003). The business case for quality: Case studies and an analysis. Health Affairs, 22(2), 17–30. Retrieved from the Walden Library databases. ( ARTICLE BELOW - MUST USE) Consider how and why you would suggest an organization address this challenge. Examine the following considerations, as well as others that would inform your response: What are the driving forces or most compelling reasons for addressing this challenge? How might financial constraints impact this situation? What other resources might be limited within the organization? How could these resource constraints influence this situation? What role might pay-for-performance play? How could the short- and long-term financial outcomes of this situation be assessed? How would the return on investment be determined? Who are the key stakeholders that would need to be included or considered in this decision? What are the expected benefits? What unanticipated consequences might occur? Note: You may find it helpful to preview the Application Assignment and use this Discussion to inform your focus for that assignment. Post by Day 4 a response to the following: Identify the quality or safety challenge you are addressing in the first line of your posting. Briefly describe the quality or safety challenge. Explain how and why you would suggest an organization address this challenge. Present a succinct analysis of three or more business considerations that inform your response. ARTICLE BELOW - MUST USE The business case for quality: Case studies and an analysis Leatherman, Sheila; Berwick, Donald; Iles, Debra; Lewin, Lawrence S; et al. Health Affairs22.2 (Mar/Apr 2003): 17-30. Turn on hit highlighting for speaking browsers by selecting the Enter button Abstract (summary) Translate Abstract The financial implications of implementing quality improvements are often poorly understood. This paper examines four cases - management of high-cost pharmaceuticals, diabetes management, smoking cessation, and wellness programs in the workplace - to understand the financial and clinical implications of improving care. I.

GEForwardThinkingJuly201431FINAL (1)Suzanne Lee

Similar to Medical Affairs Resources, Structures, & Trends Report Summary (20)

Medical Affairs Resources, Structures, and Trends (UPDATE) - Report Summary

Medical Affairs Resources, Structures & Trends Report Summary

A Day in the Life of a Medical Director

Models & Trends in REMS Program Success

Best-in-Class Strategies to Develop Effective Medical Information Groups

Pfizer Inc

EIU Value Challenge

Strategies to Increase Medical Affairs' Role in Health Outcomes Data Generati...

2nd Annual Medical Affairs Leaders Forum Asia- August 5th - 6th, 2014

PREPARATIONConsider the hospital-acquired conditions that ar.docx

Medical Science Liaison Webinarv 2009

Roles, Resources, and Managemet of Medical Science Liaisons

Strategic Audit Miller

Corporate Affairs Excellence

C H A P T E R 5S T R A T E G I C P L A N N I N G A N D

Dashboard Benchmark Evaluation Diabetes Essay.docx

Catasys, Inc. Executive Informational Overview Introduction

The Business Case for QualityDecision making in todays health car.docx

GEForwardThinkingJuly201431FINAL (1)

More from Best Practices, LLC

Communications ExcellenceBest Practices, LLC

Success Factors and Failure Points in Metabolic Product LaunchesBest Practices, LLC

Product Launch Failure & Success StudyBest Practices, LLC

New Product Launch Spend Report SummaryBest Practices, LLC

Educating KOLs, Physicians, Patients, and Payers to support successful produc...Best Practices, LLC

Scientific Publication StrategyBest Practices, LLC

CI Guidelines SummaryBest Practices, LLC

Resource Benchmarks for U.S. Pharmaceutical Managed Care OperationsBest Practices, LLC

Oncology Global Strategic MarketingBest Practices, LLC

Medical Science Liaison Services Report SummaryBest Practices, LLC

New Product Launch Spend Report SummaryBest Practices, LLC

More from Best Practices, LLC (11)

Communications Excellence

Success Factors and Failure Points in Metabolic Product Launches

Product Launch Failure & Success Study

New Product Launch Spend Report Summary

Educating KOLs, Physicians, Patients, and Payers to support successful produc...

Scientific Publication Strategy

CI Guidelines Summary

Resource Benchmarks for U.S. Pharmaceutical Managed Care Operations

Oncology Global Strategic Marketing

Medical Science Liaison Services Report Summary

New Product Launch Spend Report Summary